Abstract
In the United States between 1974 and 1977, 52% of all causes of death were attributed to cardiovascular diseases {l}. By 1981 and 1982 this figure declined slightly to 49%. Since 1974 ischemic heart diseases have accounted for approximately 65% of all cardiovascular diseases and were responsible for every third death in the United States during this period. The purported increase in the incidence of ischemic heart disease in civilized communities during the first two thirds of this century has been attributed variously to the decline and/or extinction of infectious disease, to a “less than optimal adaptation to changing patterns of lifestyle,” and to advances in diagnostic techniques. Although the mortality rate for ischemic heart disease in the United States has declined significantly (24%) since 1963 {1–3}, its incidence has not, and this entity remains the cause of more deaths in the United States than any other disease.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
World Health Statistics Annual. Vol 1: Vital Statistics and Causes of Death. Geneva: World Health Organization, 1977, pp 272–279; 1978, pp 218–225; 1979, pp 134–141; 1980, pp 108–115; 1985, pp 154–165. 750
Cooper R, Stamler L, Dyer A, Garside D: The decline in mortality form coronary heart disease, USA, 1968–1975. J Chronic Dis 31: 709–720, 1978.
Stern MP: The recent decline in ischemic heart disease mortality. Ann Intern Med 91: 630–640.
Stein O, Stein Y, Eisenberg S: Radioautographic study of the transport of125 iodine-labeled serum lipoproteins in rat aorta. Z Zellforsch Mikrosk Anat 138: 223–237, 1973.
Vlodaver Z, Edwards JE: Pathology of coronary atherosclerosis. Prog Cardiovasc Dis 14: 256–274, 1971.
Wissler RW: Principles of the pathogenesis of atherosclerosis. In: Braunwald E (ed) Heart Disease: A Textbook of Cardiovascular Medicine. Philadelphia: WB Saunders, 1980, pp 1221–1245,
Wall RT, Harker LA: The endothelium and thrombosis. Ann Rev Med 31: 361–371, 1980.
Hoak JC, Czervionke RL, Fry GL, Haycraft DL, Brotherton AA: Role of the vascular endothelium. Philos Trans Roy Soc Lond B 294: 331–338, 1981.
Nawroth PP, Stern DM: A pathway of coagulation on endothelial cells. J Cell Biochem 28: 252–264, 1985.
Reidy MA, Schwartz SM: Arterial endothelium - assessment of in vivo injury. Exp Mol Pathol 41: 419–434, 1984.
Reidy MA: Biology of disease. A reassessment of endothelial injury and arterial lesion formation. Lab Invest 53; 513–520, 1985.
Ross R, Klebanoff SJ: The smooth muscle cell. I. In vivo synthesis of connective tissue proteins. J Cell Biol 50: 159, 1971.
Wight TN, Ross R: Proteoglycans in primate arteries. II. Synthesis and secretion of glycosamino- glycans by arterial smooth muscle cells in culture. J Cell Biol 67: 675–686, 1975.
Narayanan S, Sanberg LB, Ross R, Layman D: The smooth muscle cell. III. Elastin synthesis in arterial smooth muscle cell culture. J Cell Biol 68:411 –419, 1976.
Campbell GR, Campbell JH: Smooth muscle pheno- typic changes in arterial wall homeostasis: Implications for the pathogenesis of atherosclerosis. Exp Mol Pathol 42: 139–162, 1985.
Wissler RW: The cellular pathobiology of atherosclerosis in 1983. Adv in Exp Med and Biology 183: 1–16, 1985.
Wolinsky H, Glagov S: Comparison of abdominal and thoracic aortic medial structure in mammals: Deviation of man from the usual pattern. Circ Res 25: 677–686, 1969.
Ross R, Glomset J A: The pathogenesis of atherosclerosis I. N Engl Med 295: 369–377, 1976.
Ross R, Glomset JA: The pathogenesis of atherosclerosis II. N Engl J Med 295: 420–425, 1976.
Ross R: The arterial wall and atherosclerosis. Ann Rev Med 30: 1–15, 1979.
Stemerman MB: Hemostasis, thrombosis and athero- genesis. Atheroscl Rev 6: 105–146, 1979.
Oeser J, Fehr R, Brinkmann B: Aortic and coronary atherosclerosis in a Hamburg autopsy series. Virch Arch (Pathol Anat) 384: 131–148, 1979.
Velican C, Velican D: Coronary intimal necrosis occurring as an early stage of atherosclerotic involvement. Atherosclerosis 39: 479–496, 1981.
Constantinides P: Atherosclerosis — a general survey and synthesis. Surv Synth Path Res 3: 477–498,
Altman RFA, Ramos de Souza AS: Mechanism of progression and regression of atherosclerosis. Wld Rev Nutr Diet 46: 219–251, 1985.
Jokinen MP, Clarkson TB, Prichard RW: Animal models in atherosclerosis research. Exp Mol Pathol 42: 1–28, 1985.
Flaherty JT, Ferrans VJ, Pierce JE, Carew TE, Fry DL: Localizing factors in experimental atherosclerosis. In: Likoff W, Segal BL, Insull W, Mayer JH (eds) Atherosclerosis and Coronary Heart Disease. New York: Grune and Stratton, 1972, pp 40–84.
Werb Z, Gordon S: Elastase secretion by stimulated macrophages. J Exp Med 142: 361–377, 1975.
Mendlowitz M: Arterial calcium metabolism, hypertension and arteriosclerosis. Cardiology 67: 81–89, 1981.
Fowler S, Shiu H, Haley NJ: Characterization of lipid-laden aortic cells from cholesterol-fed rabbits. Lab Invest 41: 372–378, 1979.
Watanabe T, Hirata M, Yoshikawa Y, Nagafuchi Y, Toyoshima H, Watanabe T: Role of macrophages in atherosclerosis: Sequential observations of cholesterol- induced rabbit aortic lesion by the immunoper- oxidase technique using monoclonal antimacrophage antibody. Lab Invest 53: 80–90, 1985.
Smith EB, Smith RH: Early changes in the aortic intima. Atheroscl Rev 3: 119–136, 1976.
Stein O, Halperin G, Stein Y: Cholesterylester efflux from extracellular and cellular elements of the arterial wall. Model systems in culture with choles- teryl linoleyl ether. Arteriosclerosis 6: 70–78, 1986.
Fox B, James K, Morgan B, Seed A: Distribution of fatty and fibrous plaques in young human coronary arteries. Atherosclerosis 41: 337–347, 1982.
Texon M: Hemodynamic basis of atherosclerosis. New York: McGraw-Hill, 1970.
Wright HP: Endothelial turnover. Thromb Diath Haemorrh (Suppl) 40: 79–85, 1970.
Spaet TH, Gay nor E: Vascular endothelial damage and thrombosis. Adv Cardiol 4: 47–66, 1970.
Poole JCP, Sanders AG, Florey HW: The regeneration of aortic endothelium. J Pathol Bacteriol 175: 133–143, 1958.
Baumgartner HR, Spaet TH: Endothelial replace-ment in rabbit arteries. Fed Proc 29: 710, 1970.
Spaet TH, Stemerman MB, Lejnecks I: The role of smooth muscle cells in repopulation of rabbit aortic endothelium following balloon catheter injury. Fed Proc 32: 219, 1973.
Fishman JA, Ryan GB, Karnovsky MJ: Endothelial regeneration in the rat carotid artery and the significance of endothelial denudation in the patho-genesis of myointimal thickening. Lab Invest 32: 339–351, 1975.
Chiang J, Kowada M, Ames A III, Wright RL, Majno G: Cerebral ischemia. III. Vascular changes. Am J Pathol 52: 455–76, 1968.
Gertz SD, Forbes MS, Sunaga T, Kawamura J, Rennels ML, Shimamoto T, Nelson E: Ischemic carotid endothelium: Transmission electron micro-scopic studies. Arch Pathol Lab Med 100: 522–526, 1976.
Yu MC, Bakay L, Lee JC: Ultrastructure of the central nervous system after prolonged hypoxia. II. Neuroglia and blood vessels. Acta Neuropathol (Berlin) 22: 235–244, 1972.
Boxen I: Mechanisms of atherogenesis: Endothelial hypoxia proposed as the major initiator. Med Hypoth 18: 297–311, 1985.
Hoff HF: Vascular injury: A review. In: Koller F, Brinkhous KM, Biggs R, Rodman NF, Hinnom S (eds) Vascular Factors and Thrombosis. Stuttgart: FK Schattauer Verlag, 1970, pp 121–136.
Gardner DL, Mathews MA: Ultrastructure of the wall of small arteries in early experimental rat hypertension. J Pathol 97: 51–62, 1969
Kjeldson K, Astrup P, Wanstrup J: Ultrastructural intimai changes in the rabbit aorta after a moderate carbon monoxide exposure. Atherosclerosis 16: 67– 87, 1972.
Constantinides P: The important role of endothelial changes in atherogenesis. In: Shimamoto T, Numano F (eds) Atherogenesis II. Amsterdam: Excerpta Medica 1973, pp 51–65.
Gertz SD, Kurgan A, Wajnberg RS, Nelson E: Endothelial cell damage and thrombus formation following temporary arterial occlusion: Effects of pretreatment with aspirin or heparin. J Neurosurg 50: 578–586, 1979.
Harker L, Ross R, Slichter S: Homocystine-induced arteriosclerosis: The role of endothelial injury and platelet response in its genesis. J Clin Invest 58: 731–741, 1976.
Gay nor E, Bouvier CA, Spaet TH: Vascular lesions: Possible pathogenetic bases of the generalized Schwartzman reaction. Science 170: 986–988, 1970.
Poston RN: Immunological aspects of atheroma: A review. Roy Soc Med 72: 674–681, 1979.
Ross R, Harker L; Hyperlipidemia and athero-sclerosis. Science 193: 1094–1100, 1976.
Stewart GJ, Ritchie WGM, Lynch PR: Venous endothelial damage produced by massive sticking and emigration of leukocytes. Am J Pathol 74: 507–522, 1974.
Marchesi VT: Some electron microscopic observation on interactions between leukocytes, platelets and endothelial cells in acute inflammation. Ann NY Acad Sei 116: 174–488, 1964.
Joris I, Majno G: Endothelial changes induced by arterial spasm. Am J Pathol 102: 346–358, 1981.
Gertz SD, Uretzky G, Wajnberg RS, Navot N, Gotsman MS: Endothelial cell damage and thrombus formation after partial arterial constriction: Relevance to the role of coronary artery spasm in the pathogenesis of myocardial infarction. Circulation 63: 476–486, 1981.
Karnosky MJ: Endothelial-vascular smooth muscle cell interactions. Am J Pathol 105: 200–206, 1981.
Bratzler RL, Chisolm GM, Colton CK, Smith KA, Lees RS: The distribution of labeled-low-density lipoprotein across the rabbit thoracic aortic in vivo. Atherosclerosis 25: 289–307, 1977.
Majno G, Joris I, Zand T: Atherosclerosis: New horizons. Human Pathol 16: 1–5, 1985.
Ross R, Bowen-Pope DF, Raines EW: Platelet derived growth factor: Its potential roles in wound healing, atherosclerosis,1 neoplasia, and growth and development. Ciba Found Symp 116: 98–112, 1985.
Gajdusek C, Schwartz S, Di Corleto P, Ross R: Endothelial cell derived mitogenic activity. Fed Proc 38: 1075, 1979.
Leibovich S, Ross R: A macrophage-dependent factor that stimulates the proliferation of fibroblasts in vitro. Am J Pathol 84: 501–514, 1976.
Leibowitz JO: The history of coronary heart disease. Berkeley: University of California, 1970.
Von Rokitansky C: A Manual of Pathological Anatomy (trans GE Day). London: New Sydenham Society, 1852.
Duguid JB: Thrombosis as a factor in the patho-genesis of aortic atherosclerosis. J Pathol Bacteriol 60: 57–61, 1948.
Duguid JB: Mural thrombosis in arteries. Br Med Bull 2: 36–38, 1955.
Virchow R: Phlogose und thrombose im gefä- sssystem. In: Gesammelte Abhandlungen zur Wissenschaftlichen Medizin. Frankfurt-am-Main: Meidinger, 1856.
Virchow R. Gesammelte abhandlungen zur wis-senschaftlichen medizin: Phlogose und thrombose im gefasssystem. Berlin: Max Hirsch, 1862.
Anitschkow NN: Uber Veränderungen der kan- inchenaorta bei experimentelle cholesterinsteatose. Beitr Pathol Anat 56: 379–404, 1913.
Anitschkow NN: A history of experimentation on arterial atherosclerosis in animals. In: Blumenthal HT (ed) Cowdrys arteriosclerosis, 2nd ed. Spring-field, IL: CC Thomas, 1967, pp 21–44.
Miller NE: Plasma lipoproteins, lipid transport, and atherosclerosis: Recent developments. J Clin Pathol 32: 639–650, 1979.
Asmal AC, Leary WP: Classification of hyper- lipidaemias: A time of review? South Afr Med J 50: 915–918, 1975.
Brown MS, Goldstein JL: The hyperlipoproteinemias and other disorders of lipid metabolism. In: Issel- bacher KJ, Adams RD, Braunwald E, Petersdorf RG, Wilson JD (eds) Harrison’s Principles of Internal Medicine. London: McGraw-Hill, 1980, pp 507–518.
Wolinsky H: A proposal linking clearance of circulating lipoproteins to tissue metabolic activity as a basis for understanding atherogenesis. Circ Res 47: 301–311, 1980.
Haimovici H: Atherogenesis: Recent biological concepts and clinical implications. Am J Surg 134: 174–178, 1977.
Dolder MA, Oliver MF: Myocardial infarction in young men: Study of risk factors in nine countries. Br Heart J 37: 493–503, 1975.
Hoff HF, Heideman CL, Jackson RL, Bayardo RJ, Kim H, Gotto AM Jr: Localization patterns of plasma apolipoproteins in human atherosclerotic lesions. Circ Res 37: 72–79, 1975.
Onitini AC, Lewis B, Bentall H, Jamieson C, Wisheart J, Faris I: Lipoprotein cocentrations in serum and in biopsy samples of arterial intima: A quantitative comparison. Atherosclerosis 23: 513– 519, 1976.
Castelli WP, Doyle JT, Gordon T, Hames CG, Hjortland MC, Hulley SB, Kagan A, Zukel WJ: HDL, cholesterol and other lipids in coronary heart disease: The co-operative lipoprotein phenotyping study. Circulation 55: 767–72, 1977.
Fredrickson DS, Goldstein JL, Brown MS: The familial hyperlipoproteinemias, in: Stanbury JB, Wyngaarden JB, Fredrickson DS (eds) The Metabolic basis of Inherited disease, 4th ed. New York: McGraw-Hill, 1978, pp 604–655.
Stamler J: Life styles, major risk factors, proof and public policy. Circulation 58: 3–19, 1978.
Scott RF, Daoud AS, Florentin RA: Animal models in atherosclerosis. In: Wissler RW, Geer JC (eds) The Pathogenesis of Atherosclerosis. Baltimore: Williams and Wilkins, 1972, pp 120–146.
Hoff HF, Heideman CL, Gaubatz JW, Titus JC, Gotto AM Jr: Quantitaion of apo-B in human aortic fatty streaks: A comparison with grossly normal intima and fibrous plaques. Atherosclerosis 30: 263–272, 1978.
Zilversmit DB: Atherogenesis: A postprandial phenomenon. Circulation 60: 473–485, 1979.
Steinberg D: Underlying mechanisms in atherosclerosis. J Pathol 133: 75–87, 1981.
Miller GJ: High density lipoproteins and atherosclerosis. Ann Rev Med 31: 97–108, 1980.
Stehbens WE: The role of lipid in the pathogenesis of athrosclerosis. Lancet 1: 724–726, 1975.
Thoma R: Uber die abhangigkeit dr hindegeweb- sneubildung in der arterienintima von den mechanischen Bendingungen des blutumlaufes. Virchows Arch (Pathol Anat) 93: 443–505, 1883.
Blumenthal HT, Lansing AL, Wheeler PA: Calcification of the media of the human aorta and its relation to intimal arteriosclerosis, aging and disease. Am J Pathol 20: 665–679, 1944.
Walton KW: Pathogenetic mechanisms in atherosclerosis. Am J Cardiol 35: 542–558, 1975.
Martin GM, Sprague CA: Symposium on in vi tor studies related to atherogenesis: Life histories of hyperplastoid cell lines from aorta and skin. Exp Mol Pathol 18: 125–141, 1973.
Benditt EP, Benditt JM: Evidence for a monoclonal origin of human atherosclerotic plaques. Proc Natl Acad Sei USA 70: 1753–1756, 1973.
Benditt EP: The monoclonal theory of atherogenesis. Atherogenesis. Atheroscl Rev 3: 77–85, 1978,
Failkow PJ: The origin and development of human tumors studied with cell markers. N Engl J Med 291: 26–35, 1974.
Cerilli J, Brasile L, Karmody A: Role of the vascular endothelial cell antigen system in the etiology of atherosclerosis. Ann Surg 202: 329–334, 1985.
Kosek JC, Bieber C, Lower RR: Heart graft arteriosclerosis. Transplant Proc 3: 512–514, 1971.
Svendsen UG: The importance of thymus in the pathogenesis of the chronic phase of hypertension in mice following partial infarction of the kidney. Acta Pathol Microbiol Scand A 85: 539–547, 1977.
Cochrane CG, Koffler D: Immune complex disease in experimental animals and man. Adv Immunol 16:
264, 1973.
Kniker WT, Cochrane CG: Pathogenetic factors in vascular lesions of experimental serum sickness. J Exp Med 122: 83–97, 1965.
Minick CR, Murphy GE, Campbell WG: Experimental induction of atheroarteriosclerosis by the synergy of allergic damage to arteries and a lipid rich diet. J Exp Med 124: 635–652, 1966.
Howard AN, Patelski J, Bowyer DE, Gresham GA: Atherosclerosis induced in hypercholesterolaemic baboons by immunological injury and the effects of intravenous polyunsaturated phosphatidyl choline. Atherosclerosis 14: 17–29, 1971.
Pfueller SL, Luscher EF: The effects of aggregated immunoglobulins on human blood platelets in relation to their complement fixing abilities. J Immunol 109: 517–533, 1972.
Hart MN, Tasseil SK, Sadwasser KL, Schelper RL, Moore SA: Autoimmune vasculitis resulting from in vitro immunization of lymphocytes to smooth muscle. Am J Pathol 119: 448–455, 1985.
Rodnan GP, Schumacher HR, Zvaifler NJ: Primer on the Rheumatic Diseases, 8th ed. Atlanta, Georgia! Arthritis Foundation, 1983, pp 60–77.
Liang GC, Simkin PA, MannikM; Immunoglubulins in temporal arteritis: An immunofluorescence study. Ann Intern Med 81: 19–24, 1974.
Gertz SD, Kurgan A, Eisenberg D: Aneurysm of the rabbit common carotid artery induced by per- arterial application of calcium chloride in vivo. J Clin Invest 81: 649–656, 1988.
Beaumont JL, Beaumont V: Autoimmune hyper- lipidemia. Atherosclerosis 26: 405–418, 1977.
Grotendorst GR, Seppa HEJ, Kleinman HK, Martin GR: Attachment of smooth muscle cells to collagen and their migration toward platelet-derived growth factor. Proc Natl Acad Sci USA 78: 3669–3672, 1981.
Moore S: Pathogenesis of atherosclerosis. Metabolism (Suppl 1 ) 34: 13–16, 1985.
Guy ton JR, Karnovsky MJ: Smooth muscle cell proliferation in the occluded rat carotid artery: Lack of requirement for luninal platelets. Am J Pathol 94: 585–596, 1979.
Moore S, Freidman RJ, Singal DP, Gauldie J, Blajchman MA, Roberts RS: Inhibition of injury induced thromboatherosclerotic lesions by antiplatelet serum in rabbits. Thromb Haemost 35: 70–81, 1976.
Fuster V, Bowie EJW, Lewis JC, Fass DN, Owen CA Jr, Brown AL: Resistance to arteriosclerosis in pigs with von Willebrand’s disease. J Clin Invest 61: 722–730, 1978.
Griggs TR, Reddick RL, Sultzer D, Brinkhous KM: Susceptibility of atherosclerosis in aortas and. coronary arteries of swine with von Willebrand’s disease. Am J Pathol 102: 137–145, 1981.
Moncada S, Gryglewski R, Bunting SL, Vane JR: An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature 163: 663–665, 1976.
Mustard JF, Kinlough-Rathbone RL, Packham MA: Prostaglandins and platelets. Ann Rev Med 31: 89–96, 1980
Weiss HJ: Antiplatelet therapy. N Engl J Med 298: 1344–1347, 1978.
Weiss HJ: Antiplatelet therapy. N Engl J Med 298: 1403–1406, 1978.
Grunwald J, Haudenschild CC: The influence of antiplatelet drugs on injury-stimulated migration of cultured smooth muscle cells. Artery 12: 324–336, 1985.
Plate G, Stanson AW, Hollier LH, Dewanjee MK: Drug effects on platelet deposition after endothelial injury of the rabbit aorta. J Surg Res 39: 258–266, 1985.
Parmley WW, Blumlein S, Sievers R: Modification of experimental atherosclerosis by calcium-channel blockers. Am J Cardiol 55: 165B–171B, 1985.
Carvalho ACA, Colman RW, Lees RS: Platelet function in hyperlipoproteinemia N Engl J Med 290: 434–438, 1974.
Yamazaki H, Sano T, Kobayashi I, Takahashi T, Shimamoto T: Enhancement of ADP-induced platelet aggregation by adrenaline and cholesterol in vivo and its prevention. In: Shimamoto T, Numano F (eds) Atherogenesis II. Amsterdam: Experpta Medica, 1973, pp 177–194.
Iacono JM, Binder RA, Marshall MW, Shoene NW, Jencks JA, Mackin JF: Decreased susceptibility to thrombin and collagen platelet aggregation in man fed low fat diet. Haemostasis 3: 306–318, 1975.
Moore S: Endothelial injury and atherosclerosis. Exp Mol Pathol 31: 182–190, 1979.
Hirsch EZ, Robertson AL: Selective acute arterial endothelial injury and repair. I. Methodology and surface characteristics. Atherosclerosis 28: 271–287, 1977.
Reidy MA, Schwartz SM: Endothelial regenerating. III. Time course of intimal changes after small defined injury to rat aortic endothelium. Lab Invest 44: 301–308, 1981.
Fry DL: Hemodynamic forces in atherogenesis. In: Scheinberg P (ed) Cerebrovascular Diseases. New York: Raven Press, 1976, pp 77–95.
Caplan BA, Schwartz CJ: Increased endothelial cell turn-over in areas of in vivo Evans blue up-take in the pig aorta. Atherosclerosis 17: 401–417, 1973
Langille BL, Adamson SL: Relationship between blood flow direction and endothelial cell orientation at arterial branch sites in rabbits and mice. Circ Res 48: 481–488, 1981.
Nelson E, Gertz SD, Forbes MS, Rennels ML, Heald FD, Khan MA, Farber TM, Miller E, Husain MM, Earl FL: Endothelial lesions in the aorta of egg yolk- fed miniature swine: A study by scanning and transmission electron microscopy. Exp Mol Pathol 25: 208–220, 1976.
Lewis JC, Kottke BA: Endothelial damage and thrombocyte adhesion in pigeon atherosclerosis Science 196: 1007–1009, 1977.
Geissinger HD, Mustard JF, Rowsell HC: The occurrence of microthrombi on the aortic endothelium of swine. Can Med Assoc J 87: 405–408, 1962.
Gerrity RG, Naito Hk, Richardson M, Schwartz CJ: Dietary induced atherogenesis in swine: Morphology of the intima in prelesion stage. Am J Pathol 95: 775–786, 1979.
Fry Dl: Acute vascular endothelial changes associated with increased blood velocity gradients. Circ Res 22: 165–197, 1968.
Ku DN, Giddens DP, Zarins CK, Glagov S: Pulsatile flow and atherosclerosis in the human carotid bifurcation. Positive correlation between plaque location and low and oscillating shear stress. Arteriosclerosis 5: 293–302, 1985.
Veress B, Balint A, Kocze A, Nasy Z, Jellinek H: Increasing aortic permeability by atherogenic diet. Atherosclerosis 11: 369–371, 1970.
Bretherton KN, Day AJ, Skinner SL: Effect of hypertension on the entry of 125I–754
Schwartz SM: Hypertension, endothelial injury and atherosclerosis. CardiovascMed2: 991–1002, 1977.
Wexler BC, lams SG, Judd JT: Arterial lesions in repeatedly bred spontaneously hypertensive rats. Cirs Res 38: 494–501, 1976.
Haudenschild CC, Prescott MF, Chobanian AV: Effects of hypertension and its reversal on aortic intima lesions of rat. Hypertension 2: 33–44, 1980.
Giacomelli F, Weiner J, Spiro D: The cellular pathology of experimental hypertension. V. Increased permeability of cerebral arterial vessels. Am J Pathol 59: 133–160, 1970.
Huttner I, Boutet M, More RH: Studies on protein passage through arterial endothelium. III. Effect of blood pressure levels on the passage of fine structural protein tracers through rat arterial endothelium. Lab Invest 29: 536–546, 1973.
Bevan RD: An autoradiographic and pathologica study of cellular proliferation in rabbit arteries cor-related with an increase in arterial pressure. Blood Vessels 13: 100–128, 1976.
Fry DL: Steady-state macromolecular transport across a multilayered arterial wall. Math Model 6: 353– 368, 1985.
Spence JD: Hemodynamic effects of antihypertensive drugs. Possible implications for the prevention of atherosclerosis. Hypertension (Suppl III) 6: III— 163—III—168, 1984.
Dhurandhar RW, Watt DL, Silver MD, Trimble AS, Adelman AG: Prinzmetal’s variant form of angina with arteriographic evidence of coronary spasm. Am J Cardiol 30: 902–937, 1976.
Chahine RA, Luchi RJ: Coronary arterial spasm: Culprit or bystander? Am J Cardiol 37: 936–937, 1976.
Meller J, Pichard A, Dack S: Coronary arterial spasm in Prinzmetal’s variant angina: A proved hypothesis. Am J Cardiol 37: 938–940, 1976.
Maseri A, l’Abbate A, Baroldi G, Chierchia S, Mar- zilli M, Ballestra AM, Severi S, Parodi O, Biagini A, Distante A, Pesola A: Coronary vasospasm as a possible cause of myocardial infarction. N Engl J Med 299: 1271–1277, 1978.
Braunwald E: Coronary artery spasm as a cause of myocardial ischemia. J Lab Clin Med 97: 299–312, 1981.
Hellstrom HR: The injury-spasm and vascular auto- regulatory hypothesis of ischemic disease. Am J Cardiol 49: 802–810, 1982.
Epstein SE, Cannon RO, Watson RM, Leon MB, Bonow RO, Rosing DR: Dynamic coronary obstruc-tion as a cause of angina pectoris: Implications regarding therapy. Am J Cardiol 55: 61B–68B, 1985.
Conti, CR: Myocardial infarction: Thoughts about pathogenesis and the role of coronary artery spasm. Am Heart J 110: 187–193, 1985.
Maseri A, Chierchia S, Koski JC: Mixed angina pectoris. Am J Cardiol 56: 30E–33E, 1985.
Folts JD, Crowell EB, Rowe GG: Platelet aggregation in partially obstructed vessels and its elimination with aspirin. Circulation 54: 365–370, 1976.
Turitto VT, Baumgartner HR: Platelet interaction with subendothelium in flowing rabbit blood: Effect of blood shear rate. Microvasc Res 17: 38–54, 1979.
Gutstein WH, Lataillade JN, Lewis L: Role of vaso-constriction in experimental artriosclerosis. Circ Res 10: 925–932, 1962.
Betz E, Schlote W: Responses of vessel walls to chronically applied electrical stimuli. Basic Res Cardiol 74: 10–20, 1979.
Lown B, De Silva RA: Is coronary arterial spasm a risk factor for coronary atherosclerosis? Am J Cardiol 45: 901–903, 1980.
Marzilli M, Goldstein S, Trivella MG, Palumbo C, Maseri A: Some clinical considerations regarding the relation of coronary vasospasm to coronary athero-sclerosis: A hypothetical pathogenesis. Am J Cardiol 45: 882–886, 1980.
Dalen JE, Ochene IS, Alpert JS: Coronary spasm, coronary thrombosis and myocardial infarction: A hypothesis concerning the pathopysiology of acute myocardial infarction. Am Heart J 104: 1119–1124, 1982.
Gutstein WH: Coronary spasm and coronary athe-rosclerosis. Am J Cardiol 48: 389–390, 1981.
Luchi RJ, Chahine RA: Coronary artery spasm, cor-onary artery thrombosis, and myocardiol infarction. Ann Intern Med 95: 502–505, 1981.
Braunwald E: A symposium: Experimental and clinical aspects of coronary vasoconstriction. Am J Cardiol 56: 1E–29E, 1985.
Hopkins PN, Williams RR: A survery of 246 sug-gested coronary risk factors. Atherosclerosis 40: 1–52, 1981.
Roberts WC: Relative importance of lipids and thrombus in the genesis of coronary atherosclerosis. In: Maserli A, Sobel BE, Chierchia S (eds) Hammer-smith cardiology workshop series, Vol 3. Raven Press, New York, pp. 35–38, 1987.d low density lipoprotein into the aortic intima in normal-fed rabbits. Atherosclerosis 24: 99–106, 1976.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Kluwer Academic Publishers
About this chapter
Cite this chapter
Gertz, S.D., Kurgan, A. (1989). Pathogenesis of Coronary Atherosclerosis. In: Sperelakis, N. (eds) Physiology and Pathophysiology of the Heart. Developments in Cardiovascular Medicine, vol 90. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-0873-7_36
Download citation
DOI: https://doi.org/10.1007/978-1-4613-0873-7_36
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-8222-8
Online ISBN: 978-1-4613-0873-7
eBook Packages: Springer Book Archive